戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  in children with CBL syndrome and transient juvenile myelomonocytic leukemia.
2  cure a relevant proportion of children with juvenile myelomonocytic leukemia.
3 2AF35, and SRSF2 in 371 children with MDS or juvenile myelomonocytic leukemia.
4             A 3-year-old boy was treated for juvenile myelomonocytic leukemia.
5 alignancies, including an increased risk for juvenile myelomonocytic leukemia.
6                                              Juvenile myelomonocytic leukemia, acute myeloid leukemia
7  occurs in specific human cancers, including juvenile myelomonocytic leukemia, an aggressive myelopro
8 some mutations are rare in pediatric MDS and juvenile myelomonocytic leukemia and are unlikely to ope
9 suppressor gene is frequently inactivated in juvenile myelomonocytic leukemia, and Nf1 mutant mice mo
10 s associated with marked thrombocytosis, and juvenile myelomonocytic leukemia, are clonal hematologic
11             We found missense mutations in 2 juvenile myelomonocytic leukemia cases and in 1 child wi
12 y contributing to the pathogenesis of NS and juvenile myelomonocytic leukemia caused by PTPN11 gain-o
13 e retrospectively analyzed 110 patients with juvenile myelomonocytic leukemia, given single-unit, unr
14                                              Juvenile myelomonocytic leukemia is an aggressive and fr
15                                              Juvenile myelomonocytic leukemia is an aggressive myelop
16 ularly juvenile chronic myelogenous leukemia/juvenile myelomonocytic leukemia (JCML/JMML).
17 RAS family members are frequently mutated in juvenile myelomonocytic leukemia (JMML) and acute myeloi
18 boratory features that overlap with those of juvenile myelomonocytic leukemia (JMML) and chronic myel
19 t frequently occurring mutations in sporadic juvenile myelomonocytic leukemia (JMML) and JMML-like my
20 a (AML), acute lymphoblastic leukemia (ALL), juvenile myelomonocytic leukemia (JMML) and LEOPARD synd
21         Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML) and lethally irr
22  human hematopoietic malignancies, including juvenile myelomonocytic leukemia (JMML) and T-cell lymph
23     Overactive RAS signaling is prevalent in juvenile myelomonocytic leukemia (JMML) and the myelopro
24   Chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) are myelodysplas
25 r (GM-CSF) hypersensitivity is a hallmark of juvenile myelomonocytic leukemia (JMML) but has not been
26 re that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mu
27                                              Juvenile myelomonocytic leukemia (JMML) is a disease tha
28                                              Juvenile myelomonocytic leukemia (JMML) is a lethal dise
29                                              Juvenile myelomonocytic leukemia (JMML) is a myeloprolif
30                                              Juvenile myelomonocytic leukemia (JMML) is a myeloprolif
31                                              Juvenile myelomonocytic leukemia (JMML) is a pediatric m
32                                              Juvenile myelomonocytic leukemia (JMML) is a pediatric m
33                                              Juvenile myelomonocytic leukemia (JMML) is a poor-progno
34                                              Juvenile myelomonocytic leukemia (JMML) is a rare and ag
35                                              Juvenile myelomonocytic leukemia (JMML) is a rare clonal
36                                              Juvenile myelomonocytic leukemia (JMML) is a rare hetero
37                                              Juvenile myelomonocytic leukemia (JMML) is a rare myelop
38                                              Juvenile myelomonocytic leukemia (JMML) is a rare pediat
39                                              Juvenile myelomonocytic leukemia (JMML) is a typically a
40                                              Juvenile myelomonocytic leukemia (JMML) is a unique clon
41                                              Juvenile myelomonocytic leukemia (JMML) is a unique, agg
42                                              Juvenile myelomonocytic leukemia (JMML) is an aggressive
43                                              Juvenile myelomonocytic leukemia (JMML) is an aggressive
44                                              Juvenile myelomonocytic leukemia (JMML) is an aggressive
45                                              Juvenile myelomonocytic leukemia (JMML) is an aggressive
46                                              Juvenile myelomonocytic leukemia (JMML) is an aggressive
47                                              Juvenile myelomonocytic leukemia (JMML) is an early chil
48                                              Juvenile myelomonocytic leukemia (JMML) is characterized
49                                              Juvenile myelomonocytic leukemia (JMML) is characterized
50                             Thirdly, using a juvenile myelomonocytic leukemia (JMML) patient-specific
51 f mononuclear cells from five of seven (71%) juvenile myelomonocytic leukemia (JMML) patients and fro
52 dren with myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML) treated in a uni
53 of validating the molecular underpinnings of juvenile myelomonocytic leukemia (JMML) with the generat
54 way is known to underlie the pathogenesis of juvenile myelomonocytic leukemia (JMML), a fatal childho
55 redisposes individuals to the development of juvenile myelomonocytic leukemia (JMML), a fatal myelopr
56 osphatase PTPN11 (SHP-2) are associated with juvenile myelomonocytic leukemia (JMML), a myeloprolifer
57 fibromatosis type 1 (NF1) are predisposed to juvenile myelomonocytic leukemia (JMML), an aggressive m
58 ype myelodysplastic syndrome (A-MDS), 60 had juvenile myelomonocytic leukemia (JMML), and 6 infants w
59 oodwin et al investigate the pathogenesis of juvenile myelomonocytic leukemia (JMML), demonstrating t
60 id in acute promyelocytic leukemia (APL) and juvenile myelomonocytic leukemia (JMML), we evaluated UA
61 in childhood acute leukemias, in addition to juvenile myelomonocytic leukemia (JMML), which is a myel
62 yeloproliferative disorders (MPD), including juvenile myelomonocytic leukemia (JMML).
63 ) and sAML, and also in CML blast crisis and juvenile myelomonocytic leukemia (JMML).
64  that is associated with an elevated risk of juvenile myelomonocytic leukemia (JMML).
65 n 35% of patients with de novo, nonsyndromic juvenile myelomonocytic leukemia (JMML).
66 spectrum of hematologic disorders, including juvenile myelomonocytic leukemia (JMML).
67 n for p21(ras), is frequently inactivated in juvenile myelomonocytic leukemia (JMML).
68         Children with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML).
69 sposed to myeloid malignancies, particularly juvenile myelomonocytic leukemia (JMML).
70  signaling and is inactivated in a subset of juvenile myelomonocytic leukemias (JMMLs).
71 11 mutations occur in children with sporadic juvenile myelomonocytic leukemia, myelodysplasic syndrom
72    Indeed, some pediatric leukemias, such as juvenile myelomonocytic leukemia, myeloid leukemia of Do
73                                         In 1 juvenile myelomonocytic leukemia patient, the SRSF2 muta
74                                              Juvenile myelomonocytic leukemia patients without PTPN11
75 in human chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia samples.
76  identified in human leukemias, particularly juvenile myelomonocytic leukemia, which is characterized